Krystal Biotech (KRYS)
NASDAQ:KRYS
Holding KRYS?
Track your performance easily

Krystal Biotech (KRYS) Financial Statements

444 Followers

Krystal Biotech Financial Overview

Krystal Biotech's market cap is currently ―. The company's EPS TTM is $1.767; its P/E ratio is 98.66; Krystal Biotech is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $1.24. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 83.84M$ 70.28M$ 45.25M$ 42.14M$ 8.60M
Gross Profit$ 83.84M$ 70.28M$ 45.25M$ 39.27M$ 8.60M
EBIT$ 29.78M$ 16.05M$ -4.26M$ 113.26M$ 74.50M
EBITDA$ 31.31M$ 18.07M$ -2.66M$ 115.70M$ 75.32M
Net Income Common Stockholders$ 27.18M$ 14.10M$ 932.00K$ 8.69M$ 81.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 588.32M$ 559.61M$ 538.26M$ 532.18M$ 562.07M
Total Assets$ 982.32M$ 917.66M$ 853.30M$ 818.36M$ 790.35M
Total Debt$ 7.48M$ 7.69M$ 7.89M$ 8.09M$ 8.32M
Net Debt$ -580.85M$ -551.92M$ -530.36M$ -524.08M$ -553.75M
Total Liabilities$ 96.47M$ 78.77M$ 54.05M$ 39.71M$ 34.40M
Stockholders Equity$ 885.85M$ 838.92M$ 799.24M$ 778.64M$ 755.95M
Cash Flow-
Free Cash Flow$ 57.81M$ -5.30M$ 14.63M$ -9.08M$ 76.99M
Operating Cash Flow$ 58.86M$ -4.17M$ 15.89M$ -7.23M$ -21.23M
Investing Cash Flow$ -34.33M$ -19.35M$ -25.98M$ -10.16M$ 105.19M
Financing Cash Flow$ 3.37M$ 10.64M$ 10.58M$ 2.62M$ 13.39M
Currency in USD

Krystal Biotech Earnings and Revenue History

Krystal Biotech Debt to Assets

Krystal Biotech Cash Flow

Krystal Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis